BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liverani E, Scaioli E, Digby RJ, Bellanova M, Belluzzi A. How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol 2016; 22(3): 1017-1033 [PMID: 26811644 DOI: 10.3748/wjg.v22.i3.1017]
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1017.htm
Number Citing Articles
1
Mario C. Manresa, Cormac T. Taylor. Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier FunctionCellular and Molecular Gastroenterology and Hepatology 2017; 3(3): 303 doi: 10.1016/j.jcmgh.2017.02.004
2
Bandik Föh, Torsten Schröder, Henrik Oster, Stefanie Derer, Christian Sina. Seasonal Clock Changes Are Underappreciated Health Risks—Also in IBD?Frontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00103
3
Rodrigo de Oliveira Formiga, Edvaldo Balbino Alves Júnior, Roseane Carvalho Vasconcelos, Gerlane Coelho Bernardo Guerra, Aurigena Antunes de Araújo, Thaís Gomes de Carvalho, Vinícius Barreto Garcia, Raimundo Fernandes de Araújo Junior, Francisco Allysson Assis Ferreira Gadelha, Giciane Carvalho Vieira, Marianna Vieira Sobral, José Maria Barbosa Filho, Fernando Spiller, Leônia Maria Batista. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and ImmunomodulationInternational Journal of Molecular Sciences 2020; 21(16): 5870 doi: 10.3390/ijms21165870
4
Eleonora Scaioli, Andrea Belluzzi, Luigi Ricciardiello, Daniele Del Rio, Enrica Rotondo, Pedro Mena, Eleonora Derlindati, Francesca Danesi. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trialTrials 2019; 20(1) doi: 10.1186/s13063-019-3321-8
5
Kelcie Witges, Kathryn Sexton, Lesley A Graff, Laura E Targownik, Lisa M Lix, Clove Haviva, James Stone, Leigh Anne Shafer, Kathy Vagianos, Charles N Bernstein. What Is a Flare? The Manitoba Living With IBD StudyInflammatory Bowel Diseases 2021;  doi: 10.1093/ibd/izab192
6
Florent Clerc, Mislav Novokmet, Viktoria Dotz, Karli R. Reiding, Noortje de Haan, Guinevere S.M. Kammeijer, Hans Dalebout, Marco R. Bladergroen, Frano Vukovic, Erdmann Rapp, Stephan R. Targan, Gildardo Barron, Natalia Manetti, Anna Latiano, Dermot P.B. McGovern, Vito Annese, Gordan Lauc, Manfred Wuhrer, Jack Satsangi, Elaine R. Nimmo, Nicholas T. Ventham, Hazel Drummond, Rahul Kalla, Alex T. Adams, Kate O'Leary, Ray Boyapati, David C. Wilson, Victoria Merrick, Harry Campbell, Evropi Theodoratou, Igor Rudan, Nicholas A. Kennedy, Daryl L. Fernandes, Daniel I.R. Spencer, Richard A. Gardner, Archana Shubhakar, Paulina A. Urbanowicz, Irena Trbojević-Akmačić, Jasminka Krištić, Jerko Štambuk, Maja Pučić-Baković, Marija Vilaj, Marija Pezer, Genadij Razdorov, Mirna Šimurina, Olga Gornik, Giuseppe Biscaglia, Orazio Palmieri, Fabrizio Bossa, Renata D'incà, Silvio Danese, Anna Kohn, Iain K. Pemberton, Daniel Kolarich, Vlatka Zoldos, Yurii Aulchenko, Marieke Pierik, Daisy Jonkers, Tim van den Heuvel. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel DiseasesGastroenterology 2018; 155(3): 829 doi: 10.1053/j.gastro.2018.05.030
7
Michael Chiorean, Anita Afzali, Raymond K Cross, Dendy Macaulay, Jenny Griffith, Anthony Wang, Viviana Garcia-Horton. Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or VedolizumabCrohn's & Colitis 360 2020; 2(2) doi: 10.1093/crocol/otaa031
8
Trilokesh D. Kidambi, Yu Liang, Pejman Motarjem, Rizvan Mirza, Alice Han, Marjorie Hein, Dupinder Singh, James L. Lin, Cornelia Banciu-Odell, Robert Toroussian, Michael W. Lew, Saro Manoukian. Episodic, severe abdominal pain due to isolated jejunal Crohn’s diseaseClinical Journal of Gastroenterology 2021; 14(4): 1084 doi: 10.1007/s12328-021-01421-7
9
Tzipi Braun, Ayelet Di Segni, Marina BenShoshan, Sandra Neuman, Nina Levhar, Michael Bubis, Orit Picard, Katya Sosnovski, Gilat Efroni, Sarit Farage Barhom, Efrat Glick Saar, Avishay Lahad, Batia Weiss, Doron Yablecovitch, Adi Lahat, Rami Eliakim, Uri Kopylov, Shomron Ben-Horin, Yael Haberman. Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease FlaresAmerican Journal of Gastroenterology 2019; 114(7): 1142 doi: 10.14309/ajg.0000000000000136
10
Aleksandra Glapa-Nowak, Mariusz Szczepanik, Jarosław Kwiecień, Anna Szaflarska-Popławska, Anna Flak-Wancerz, Barbara Iwańczak, Marcin Osiecki, Jarosław Kierkuś, Tomasz Pytrus, Dariusz Lebensztejn, Tomasz Banasiewicz, Aleksandra Banaszkiewicz, Jarosław Walkowiak. Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease—A Multi-Centre Cross-Sectional StudyJournal of Clinical Medicine 2020; 9(12): 3957 doi: 10.3390/jcm9123957
11
Nicolas Pierre, Dominique Baiwir, Vân Anh Huynh-Thu, Gabriel Mazzucchelli, Nicolas Smargiasso, Edwin De Pauw, Yoram Bouhnik, David Laharie, Jean-Frédéric Colombel, Marie-Alice Meuwis, Edouard Louis. Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn’s patients: a proteomics-based studyGut 2021; 70(8): 1450 doi: 10.1136/gutjnl-2020-322100
12
Thomas Chateau, Laurent Peyrin‐Biroulet. Evolving therapeutic goals in Crohn's disease managementUnited European Gastroenterology Journal 2020; 8(2): 133 doi: 10.1177/2050640619887316
13
Panupong Hansrivijit, Max M. Puthenpura, Charat Thongprayoon, Himmat S. Brar, Tarun Bathini, Karthik Kovvuru, Swetha R. Kanduri, Karn Wijarnpreecha, Wisit Cheungpasitporn. Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-AnalysisMedical Sciences 2020; 8(3): 39 doi: 10.3390/medsci8030039
14
Alyce Anderson, Cynthia Cherfane, Benjamin Click, Claudia Ramos-Rivers, Ioannis E Koutroubakis, Jana G Hashash, Dmitriy Babichenko, Gong Tang, Michael Dunn, Arthur Barrie, Siobhan Proksell, Jeffrey Dueker, Elyse Johnston, Marc Schwartz, David G Binion. Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History RegistryInflammatory Bowel Diseases 2021;  doi: 10.1093/ibd/izab031
15
María E. Prados, Adela García-Martín, Juan D. Unciti-Broceta, Belén Palomares, Juan A. Collado, Alberto Minassi, Marco A. Calzado, Giovanni Appendino, Eduardo Muñoz. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel diseaseActa Pharmacologica Sinica 2021; 42(7): 1124 doi: 10.1038/s41401-020-0497-0
16
Marina Moreira de Castro, Ligiana Pires Corona, Lívia Bitencourt Pascoal, Josiane Érica Miyamoto, Leticia Martins Ignacio-Souza, Maria de Lourdes Setsuko Ayrizono, Marcio Alberto Torsoni, Adriana Souza Torsoni, Raquel Franco Leal, Marciane Milanski. Dietary Patterns Associated to Clinical Aspects in Crohn’s Disease PatientsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64024-1
17
Y. B. Uspenskaya, S. J. Belogubova. DIAGNOSTIC POSSIBILITIES OF FECAL CALPROTECTIN APPLICATION IN PATIENTS WITH INFLAMMATORY DOWEL DISEASES DURING PREGNANCY (literature review and clinical observations)Koloproktologia 2018; (2): 95 doi: 10.33878/2073-7556-2018-0-2-95-101
18
Elena Milanesi, Maria Dobre, Teodora E. Manuc, Gabriel Becheanu, Cristian G. Tieranu, Elena M. Ionescu, Mircea Manuc. Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patientsDrug Development Research 2019; 80(6): 831 doi: 10.1002/ddr.21566
19
Ashwin N Ananthakrishnan. Microbiome-Based Biomarkers for IBDInflammatory Bowel Diseases 2020; 26(10): 1463 doi: 10.1093/ibd/izaa071
20
Xiuli Zuo, Tian Ma. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease2020; : 257 doi: 10.1016/B978-0-12-814811-2.00018-9
21
Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, Dobriana Georgieva Panova, Ekaterina Ivanova Ivanova - Todorova, Kalina Dinkova Tumangelova - Yuzeir, Ekaterina Krasimirova Kurteva, Dobroslav Stanimirov Kyurkchiev, Siragan Arshavir Deredjan, Rosen Kirilov Nikolov, Iskra Petrova Altankova, Lyudmila Mateva Vladimirova. Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s DiseaseAnnals of Colorectal Research 2018; 6(1) doi: 10.5812/acr.68674
22
Ammar Hassanzadeh Keshteli, Floris F van den Brand, Karen L Madsen, Rupasri Mandal, Rosica Valcheva, Karen I Kroeker, Beomsoo Han, Rhonda C Bell, Janis Cole, Thomas Hoevers, David S Wishart, Richard N Fedorak, Levinus A Dieleman. Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort studyWorld Journal of Gastroenterology 2017; 23(21): 3890-3899 doi: 10.3748/wjg.v23.i21.3890
23
H. J. Galipeau, E. F. Verdu. The complex task of measuring intestinal permeability in basic and clinical scienceNeurogastroenterology & Motility 2016; 28(7): 957 doi: 10.1111/nmo.12871
24
Harald Engler, Sigrid Elsenbruch, Laura Rebernik, Janina Köcke, Holger Cramer, Margarita Schöls, Jost Langhorst. Stress burden and neuroendocrine regulation of cytokine production in patients with ulcerative colitis in remissionPsychoneuroendocrinology 2018; 98: 101 doi: 10.1016/j.psyneuen.2018.08.009
25
Analysis of the Nutrients and Food Products Intake of Polish Males with Ulcerative Colitis in RemissionNutrients 2019; 11(10): 2333 doi: 10.3390/nu11102333
26
Rikke Edelbo, Malte Hjerrild, Palle Bager. Impact of remission on worries experienced by patients receiving biologic therapy for inflammatory bowel diseaseGastrointestinal Nursing 2020; 18(7): 28 doi: 10.12968/gasn.2020.18.7.28
27
Masaaki Funata, Yasunori Nio, Derek M. Erion, Wendy L. Thompson, Takanori Takebe. The promise of human organoids in the digestive systemCell Death & Differentiation 2021; 28(1): 84 doi: 10.1038/s41418-020-00661-3
28
Aaron S Bancil, Alicia M Sandall, Megan Rossi, Benoit Chassaing, James O Lindsay, Kevin Whelan. Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2021; 15(6): 1068 doi: 10.1093/ecco-jcc/jjaa254
29
Walter Reinisch, Remo Panaccione, Peter Bossuyt, Filip Baert, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, William J Sandborn, Stefan Schreiber, Sofie Berg, Qian Zhou, Kristina Kligys, Ezequiel Neimark, Ahmed A Suleiman, Geert D’Haens, Jean-Frederic Colombel. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM StudyInflammatory Bowel Diseases 2020; 26(10): 1562 doi: 10.1093/ibd/izaa025
30
Juan Sebastian LASA, Ignacio ZUBIAURRE, Astrid RAUSCH, Pablo OLIVERA. PLACEBO USE IN THE CONTEXT OF INFLAMMATORY BOWEL DISEASE CLINICAL TRIALSArquivos de Gastroenterologia 2020; 57(1): 87 doi: 10.1590/s0004-2803.202000000-15
31
Rayna Shentova-Eneva, Tsvetelina Velikova. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New?Gastroenterology Insights 2020; 11(2): 58 doi: 10.3390/gastroent11020009
32
Sherman Picardo, Mansour Altuwaijri, Shane M. Devlin, Cynthia H. Seow. Complementary and alternative medications in the management of inflammatory bowel diseaseTherapeutic Advances in Gastroenterology 2020; 13: 175628482092755 doi: 10.1177/1756284820927550
33
Nienke Z Borren, Damian Plichta, Amit D Joshi, Gracia Bonilla, Ruslan Sadreyev, Hera Vlamakis, Ramnik J Xavier, Ashwin N Ananthakrishnan. Multi-“-Omics” Profiling in Patients With Quiescent Inflammatory Bowel Disease Identifies Biomarkers Predicting RelapseInflammatory Bowel Diseases 2020; 26(10): 1524 doi: 10.1093/ibd/izaa183
34
B Lo, M K Vester-Andersen, I Vind, M Prosberg, M Dubinsky, C A Siegel, F Bendtsen, J Burisch. Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception CohortJournal of Crohn's and Colitis 2018; 12(3): 265 doi: 10.1093/ecco-jcc/jjx138
35
Michael Bramhall, Kevin Rich, Ajanta Chakraborty, Larisa Logunova, Namshik Han, James Wilson, John McLaughlin, Andy Brass, Sheena M Cruickshank. Differential Expression of Soluble Receptor for Advanced Glycation End-products in Mice Susceptible or Resistant to Chronic ColitisInflammatory Bowel Diseases 2020; 26(3): 360 doi: 10.1093/ibd/izz311
36
Yasmin Hadian, Daniel Fregoso, Chuong Nguyen, Michelle D. Bagood, Sara E. Dahle, Melanie G. Gareau, Roslyn Rivkah Isseroff. Microbiome‐skin‐brain axis: A novel paradigm for cutaneous woundsWound Repair and Regeneration 2020; 28(3): 282 doi: 10.1111/wrr.12800
37
Dominika Głąbska, Dominika Guzek, Karolina Gałązka, Gustaw Lech. Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in RemissionJournal of Clinical Medicine 2020; 9(3): 771 doi: 10.3390/jcm9030771
38
Seoyeon Kim, Byung-Hee Lee, Xiuyu Zhang, Jae-Woo Park, Sle Lee, Hyangsook Lee. Adjunctive herbal medicine therapy for inflammatory bowel disease: A systematic review and meta-analysisEuropean Journal of Integrative Medicine 2017; 12: 12 doi: 10.1016/j.eujim.2017.03.009
39
Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, Tomas Vaňásek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, Walter Reinisch, William J Sandborn, Paul Rutgeerts, Daniel Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Paloma Mendez, Joel Petersson, Kori Wallace, Anne M Robinson, Roopal B Thakkar, Geert D'Haens. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialThe Lancet 2017; 390(10114): 2779 doi: 10.1016/S0140-6736(17)32641-7
40
Dominika Skolmowska, Dominika Głąbska, Dominika Guzek, Gustaw Lech. Association between Dietary Isoflavone Intake and Ulcerative Colitis Symptoms in Polish Caucasian IndividualsNutrients 2019; 11(8): 1936 doi: 10.3390/nu11081936
41
Satoshi Hiyama, Hideki Iijima, Syoichiro Kawai, Akira Mukai, Eri Shiraishi, Shuko Iwatani, Toshio Yamaguchi, Manabu Araki, Yoshito Hayashi, Shinichiro Shinzaki, Tsunekazu Mizushima, Masahiko Tsujii, Tetsuo Takehara. Narrow-band imaging with magnifying endoscopy for Peyer's patches is useful in predicting the recurrence of remissive patients with ulcerative colitisIntestinal Research 2016; 14(4): 314 doi: 10.5217/ir.2016.14.4.314
42
Kendra Kamp, Gwen Wyatt, Sharon Dudley-Brown, Kelly Brittain, Barbara Given. Using cognitive interviewing to improve questionnaires: An exemplar study focusing on individual and condition-specific factorsApplied Nursing Research 2018; 43: 121 doi: 10.1016/j.apnr.2018.06.007
43
Badrinath Jagannath, Kai-Chun Lin, Madhavi Pali, Devang Sankhala, Sriram Muthukumar, Shalini Prasad. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2020; 26(10): 1533 doi: 10.1093/ibd/izaa191
44
Cristiana Popp, Radu Bogdan Mateescu. New Concepts in Inflammatory Bowel Disease2018;  doi: 10.5772/intechopen.72893
45
Naïm Ouldali, Jean-Pierre Hugot, Jérôme Viala, Mohamed Damir, Christine Martinez-Vinson, Ulrich Meinzer. Early Arthritis Is Associated With Failure of Immunosuppressive Drugs and Severe Pediatric Crohn’s Disease EvolutionInflammatory Bowel Diseases 2018; 24(11): 2423 doi: 10.1093/ibd/izy137
46
Karin Amcoff, Yang Cao, Yaroslava Zhulina, Maria Lampinen, Jonas Halfvarson, Marie Carlson. Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2019; 54(10): 1237 doi: 10.1080/00365521.2019.1670251
47
Doron Yablecovitch, Uri Kopylov, Adi Lahat, Michal M. Amitai, Eyal Klang, Dana Ben-Ami Shor, Sandra Neuman, Nina Levhar, Ella Fudim, Benjamin Avidan, Ido Laish, Limor Selinger, Noam Zingboim-Orbach, Orit Picard, Miri Yavzori, Rami Eliakim, Shomron Ben-Horin. Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysisTherapeutic Advances in Gastroenterology 2019; 12: 175628481988159 doi: 10.1177/1756284819881590
48
Elena Vegni, Daniela Gilardi, Stefanos Bonovas, Bianca E Corrò, Julia Menichetti, Daniela Leone, Allocca Mariangela, Federica Furfaro, Silvio Danese, Gionata Fiorino. Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort StudyJournal of Crohn's and Colitis 2019; 13(4): 417 doi: 10.1093/ecco-jcc/jjy183
49
Murat Cakir, Elif Sag, Guzide Dogan, Fatih Unal, Erhun Kasirga. Clinical significance of low transaminase levels in children with inflammatory bowel diseaseWorld Journal of Pediatrics 2019; 15(2): 143 doi: 10.1007/s12519-019-00235-5
50
Mahesh Gajendran, Priyadarshini Loganathan, Guillermo Jimenez, Anthony P. Catinella, Nathaniel Ng, Chandraprakash Umapathy, Nathalie Ziade, Jana G. Hashash. A comprehensive review and update on ulcerative colitis,Disease-a-Month 2019; 65(12): 100851 doi: 10.1016/j.disamonth.2019.02.004
51
Kelly C Cushing, Richard Mclean, Keely G McDonald, Jenny K Gustafsson, Kathryn A Knoop, Devesha H Kulkarni, R Balfour Sartor, Rodney D Newberry. Predicting Risk of Postoperative Disease Recurrence in Crohn’s Disease: Patients With Indolent Crohn’s Disease Have Distinct Whole Transcriptome Profiles at the Time of First SurgeryInflammatory Bowel Diseases 2019; 25(1): 180 doi: 10.1093/ibd/izy228